Global Poliomyelitis Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Poliomyelitis Vaccine market size was valued at USD 730.3 million in 2023 and is forecast to a readjusted size of USD 850.6 million by 2030 with a CAGR of 2.2% during review period.
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Poliomyelitis Vaccine industry chain, the market status of VAPP (Poliomyelitis Vaccine ?, Poliomyelitis Vaccine ?), VDPV (Poliomyelitis Vaccine ?, Poliomyelitis Vaccine ?), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Poliomyelitis Vaccine.
Regionally, the report analyzes the Poliomyelitis Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Poliomyelitis Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Poliomyelitis Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Poliomyelitis Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Poliomyelitis Vaccine ?, Poliomyelitis Vaccine ?).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Poliomyelitis Vaccine market.
Regional Analysis: The report involves examining the Poliomyelitis Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Poliomyelitis Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Poliomyelitis Vaccine:
Company Analysis: Report covers individual Poliomyelitis Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Poliomyelitis Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (VAPP, VDPV).
Technology Analysis: Report covers specific technologies relevant to Poliomyelitis Vaccine. It assesses the current state, advancements, and potential future developments in Poliomyelitis Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Poliomyelitis Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Poliomyelitis Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Poliomyelitis Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Poliomyelitis Vaccine, with price, sales, revenue and global market share of Poliomyelitis Vaccine from 2019 to 2024.
Chapter 3, the Poliomyelitis Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Poliomyelitis Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Poliomyelitis Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Poliomyelitis Vaccine.
Chapter 14 and 15, to describe Poliomyelitis Vaccine sales channel, distributors, customers, research findings and conclusion.
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Poliomyelitis Vaccine industry chain, the market status of VAPP (Poliomyelitis Vaccine ?, Poliomyelitis Vaccine ?), VDPV (Poliomyelitis Vaccine ?, Poliomyelitis Vaccine ?), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Poliomyelitis Vaccine.
Regionally, the report analyzes the Poliomyelitis Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Poliomyelitis Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Poliomyelitis Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Poliomyelitis Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Poliomyelitis Vaccine ?, Poliomyelitis Vaccine ?).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Poliomyelitis Vaccine market.
Regional Analysis: The report involves examining the Poliomyelitis Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Poliomyelitis Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Poliomyelitis Vaccine:
Company Analysis: Report covers individual Poliomyelitis Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Poliomyelitis Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (VAPP, VDPV).
Technology Analysis: Report covers specific technologies relevant to Poliomyelitis Vaccine. It assesses the current state, advancements, and potential future developments in Poliomyelitis Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Poliomyelitis Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Poliomyelitis Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Poliomyelitis Vaccine ?
- Poliomyelitis Vaccine ?
- Poliomyelitis Vaccine ?
- Oral Poliomyelitis Vaccine
- VAPP
- VDPV
- GSK
- Sanofi-Pasteur
- Merck
- Crucell
- China National Biotech Group
- Eli Lilly
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Poliomyelitis Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Poliomyelitis Vaccine, with price, sales, revenue and global market share of Poliomyelitis Vaccine from 2019 to 2024.
Chapter 3, the Poliomyelitis Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Poliomyelitis Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Poliomyelitis Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Poliomyelitis Vaccine.
Chapter 14 and 15, to describe Poliomyelitis Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Poliomyelitis Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Poliomyelitis Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Poliomyelitis Vaccine ?
1.3.3 Poliomyelitis Vaccine ?
1.3.4 Poliomyelitis Vaccine ?
1.3.5 Oral Poliomyelitis Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Poliomyelitis Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 VAPP
1.4.3 VDPV
1.5 Global Poliomyelitis Vaccine Market Size & Forecast
1.5.1 Global Poliomyelitis Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Poliomyelitis Vaccine Sales Quantity (2019-2030)
1.5.3 Global Poliomyelitis Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Poliomyelitis Vaccine Product and Services
2.1.4 GSK Poliomyelitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments/Updates
2.2 Sanofi-Pasteur
2.2.1 Sanofi-Pasteur Details
2.2.2 Sanofi-Pasteur Major Business
2.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Product and Services
2.2.4 Sanofi-Pasteur Poliomyelitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi-Pasteur Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Poliomyelitis Vaccine Product and Services
2.3.4 Merck Poliomyelitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments/Updates
2.4 Crucell
2.4.1 Crucell Details
2.4.2 Crucell Major Business
2.4.3 Crucell Poliomyelitis Vaccine Product and Services
2.4.4 Crucell Poliomyelitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Crucell Recent Developments/Updates
2.5 China National Biotech Group
2.5.1 China National Biotech Group Details
2.5.2 China National Biotech Group Major Business
2.5.3 China National Biotech Group Poliomyelitis Vaccine Product and Services
2.5.4 China National Biotech Group Poliomyelitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 China National Biotech Group Recent Developments/Updates
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Poliomyelitis Vaccine Product and Services
2.6.4 Eli Lilly Poliomyelitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Eli Lilly Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: POLIOMYELITIS VACCINE BY MANUFACTURER
3.1 Global Poliomyelitis Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Poliomyelitis Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Poliomyelitis Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Poliomyelitis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Poliomyelitis Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Poliomyelitis Vaccine Manufacturer Market Share in 2023
3.5 Poliomyelitis Vaccine Market: Overall Company Footprint Analysis
3.5.1 Poliomyelitis Vaccine Market: Region Footprint
3.5.2 Poliomyelitis Vaccine Market: Company Product Type Footprint
3.5.3 Poliomyelitis Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Poliomyelitis Vaccine Market Size by Region
4.1.1 Global Poliomyelitis Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Poliomyelitis Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Poliomyelitis Vaccine Average Price by Region (2019-2030)
4.2 North America Poliomyelitis Vaccine Consumption Value (2019-2030)
4.3 Europe Poliomyelitis Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Poliomyelitis Vaccine Consumption Value (2019-2030)
4.5 South America Poliomyelitis Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Poliomyelitis Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Poliomyelitis Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Poliomyelitis Vaccine Consumption Value by Type (2019-2030)
5.3 Global Poliomyelitis Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Poliomyelitis Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Poliomyelitis Vaccine Consumption Value by Application (2019-2030)
6.3 Global Poliomyelitis Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Poliomyelitis Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Poliomyelitis Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Poliomyelitis Vaccine Market Size by Country
7.3.1 North America Poliomyelitis Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Poliomyelitis Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Poliomyelitis Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Poliomyelitis Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Poliomyelitis Vaccine Market Size by Country
8.3.1 Europe Poliomyelitis Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Poliomyelitis Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Poliomyelitis Vaccine Market Size by Region
9.3.1 Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Poliomyelitis Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Poliomyelitis Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Poliomyelitis Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Poliomyelitis Vaccine Market Size by Country
10.3.1 South America Poliomyelitis Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Poliomyelitis Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Poliomyelitis Vaccine Market Size by Country
11.3.1 Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Poliomyelitis Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Poliomyelitis Vaccine Market Drivers
12.2 Poliomyelitis Vaccine Market Restraints
12.3 Poliomyelitis Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Poliomyelitis Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Poliomyelitis Vaccine
13.3 Poliomyelitis Vaccine Production Process
13.4 Poliomyelitis Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Poliomyelitis Vaccine Typical Distributors
14.3 Poliomyelitis Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Poliomyelitis Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Poliomyelitis Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Poliomyelitis Vaccine ?
1.3.3 Poliomyelitis Vaccine ?
1.3.4 Poliomyelitis Vaccine ?
1.3.5 Oral Poliomyelitis Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Poliomyelitis Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 VAPP
1.4.3 VDPV
1.5 Global Poliomyelitis Vaccine Market Size & Forecast
1.5.1 Global Poliomyelitis Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Poliomyelitis Vaccine Sales Quantity (2019-2030)
1.5.3 Global Poliomyelitis Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Poliomyelitis Vaccine Product and Services
2.1.4 GSK Poliomyelitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments/Updates
2.2 Sanofi-Pasteur
2.2.1 Sanofi-Pasteur Details
2.2.2 Sanofi-Pasteur Major Business
2.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Product and Services
2.2.4 Sanofi-Pasteur Poliomyelitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi-Pasteur Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Poliomyelitis Vaccine Product and Services
2.3.4 Merck Poliomyelitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments/Updates
2.4 Crucell
2.4.1 Crucell Details
2.4.2 Crucell Major Business
2.4.3 Crucell Poliomyelitis Vaccine Product and Services
2.4.4 Crucell Poliomyelitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Crucell Recent Developments/Updates
2.5 China National Biotech Group
2.5.1 China National Biotech Group Details
2.5.2 China National Biotech Group Major Business
2.5.3 China National Biotech Group Poliomyelitis Vaccine Product and Services
2.5.4 China National Biotech Group Poliomyelitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 China National Biotech Group Recent Developments/Updates
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Poliomyelitis Vaccine Product and Services
2.6.4 Eli Lilly Poliomyelitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Eli Lilly Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: POLIOMYELITIS VACCINE BY MANUFACTURER
3.1 Global Poliomyelitis Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Poliomyelitis Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Poliomyelitis Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Poliomyelitis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Poliomyelitis Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Poliomyelitis Vaccine Manufacturer Market Share in 2023
3.5 Poliomyelitis Vaccine Market: Overall Company Footprint Analysis
3.5.1 Poliomyelitis Vaccine Market: Region Footprint
3.5.2 Poliomyelitis Vaccine Market: Company Product Type Footprint
3.5.3 Poliomyelitis Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Poliomyelitis Vaccine Market Size by Region
4.1.1 Global Poliomyelitis Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Poliomyelitis Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Poliomyelitis Vaccine Average Price by Region (2019-2030)
4.2 North America Poliomyelitis Vaccine Consumption Value (2019-2030)
4.3 Europe Poliomyelitis Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Poliomyelitis Vaccine Consumption Value (2019-2030)
4.5 South America Poliomyelitis Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Poliomyelitis Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Poliomyelitis Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Poliomyelitis Vaccine Consumption Value by Type (2019-2030)
5.3 Global Poliomyelitis Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Poliomyelitis Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Poliomyelitis Vaccine Consumption Value by Application (2019-2030)
6.3 Global Poliomyelitis Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Poliomyelitis Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Poliomyelitis Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Poliomyelitis Vaccine Market Size by Country
7.3.1 North America Poliomyelitis Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Poliomyelitis Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Poliomyelitis Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Poliomyelitis Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Poliomyelitis Vaccine Market Size by Country
8.3.1 Europe Poliomyelitis Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Poliomyelitis Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Poliomyelitis Vaccine Market Size by Region
9.3.1 Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Poliomyelitis Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Poliomyelitis Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Poliomyelitis Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Poliomyelitis Vaccine Market Size by Country
10.3.1 South America Poliomyelitis Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Poliomyelitis Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Poliomyelitis Vaccine Market Size by Country
11.3.1 Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Poliomyelitis Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Poliomyelitis Vaccine Market Drivers
12.2 Poliomyelitis Vaccine Market Restraints
12.3 Poliomyelitis Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Poliomyelitis Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Poliomyelitis Vaccine
13.3 Poliomyelitis Vaccine Production Process
13.4 Poliomyelitis Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Poliomyelitis Vaccine Typical Distributors
14.3 Poliomyelitis Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Poliomyelitis Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Poliomyelitis Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Poliomyelitis Vaccine Product and Services
Table 6. GSK Poliomyelitis Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GSK Recent Developments/Updates
Table 8. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi-Pasteur Major Business
Table 10. Sanofi-Pasteur Poliomyelitis Vaccine Product and Services
Table 11. Sanofi-Pasteur Poliomyelitis Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi-Pasteur Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Poliomyelitis Vaccine Product and Services
Table 16. Merck Poliomyelitis Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck Recent Developments/Updates
Table 18. Crucell Basic Information, Manufacturing Base and Competitors
Table 19. Crucell Major Business
Table 20. Crucell Poliomyelitis Vaccine Product and Services
Table 21. Crucell Poliomyelitis Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Crucell Recent Developments/Updates
Table 23. China National Biotech Group Basic Information, Manufacturing Base and Competitors
Table 24. China National Biotech Group Major Business
Table 25. China National Biotech Group Poliomyelitis Vaccine Product and Services
Table 26. China National Biotech Group Poliomyelitis Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. China National Biotech Group Recent Developments/Updates
Table 28. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 29. Eli Lilly Major Business
Table 30. Eli Lilly Poliomyelitis Vaccine Product and Services
Table 31. Eli Lilly Poliomyelitis Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Eli Lilly Recent Developments/Updates
Table 33. Global Poliomyelitis Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 34. Global Poliomyelitis Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Poliomyelitis Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 36. Market Position of Manufacturers in Poliomyelitis Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Poliomyelitis Vaccine Production Site of Key Manufacturer
Table 38. Poliomyelitis Vaccine Market: Company Product Type Footprint
Table 39. Poliomyelitis Vaccine Market: Company Product Application Footprint
Table 40. Poliomyelitis Vaccine New Market Entrants and Barriers to Market Entry
Table 41. Poliomyelitis Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Poliomyelitis Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 43. Global Poliomyelitis Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 44. Global Poliomyelitis Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Poliomyelitis Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Poliomyelitis Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 47. Global Poliomyelitis Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 48. Global Poliomyelitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Global Poliomyelitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Global Poliomyelitis Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Poliomyelitis Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Poliomyelitis Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 53. Global Poliomyelitis Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 54. Global Poliomyelitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 55. Global Poliomyelitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 56. Global Poliomyelitis Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Poliomyelitis Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Poliomyelitis Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 59. Global Poliomyelitis Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 60. North America Poliomyelitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 61. North America Poliomyelitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 62. North America Poliomyelitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 63. North America Poliomyelitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 64. North America Poliomyelitis Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 65. North America Poliomyelitis Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 66. North America Poliomyelitis Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Poliomyelitis Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Poliomyelitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Europe Poliomyelitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Europe Poliomyelitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Europe Poliomyelitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Europe Poliomyelitis Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 73. Europe Poliomyelitis Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 74. Europe Poliomyelitis Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Poliomyelitis Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 77. Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 78. Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 79. Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 80. Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 81. Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 82. Asia-Pacific Poliomyelitis Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Poliomyelitis Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Poliomyelitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 85. South America Poliomyelitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 86. South America Poliomyelitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 87. South America Poliomyelitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 88. South America Poliomyelitis Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 89. South America Poliomyelitis Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 90. South America Poliomyelitis Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Poliomyelitis Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 93. Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 94. Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 97. Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 98. Middle East & Africa Poliomyelitis Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Poliomyelitis Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Poliomyelitis Vaccine Raw Material
Table 101. Key Manufacturers of Poliomyelitis Vaccine Raw Materials
Table 102. Poliomyelitis Vaccine Typical Distributors
Table 103. Poliomyelitis Vaccine Typical Customers
Table 1. Global Poliomyelitis Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Poliomyelitis Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Poliomyelitis Vaccine Product and Services
Table 6. GSK Poliomyelitis Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GSK Recent Developments/Updates
Table 8. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi-Pasteur Major Business
Table 10. Sanofi-Pasteur Poliomyelitis Vaccine Product and Services
Table 11. Sanofi-Pasteur Poliomyelitis Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi-Pasteur Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Poliomyelitis Vaccine Product and Services
Table 16. Merck Poliomyelitis Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck Recent Developments/Updates
Table 18. Crucell Basic Information, Manufacturing Base and Competitors
Table 19. Crucell Major Business
Table 20. Crucell Poliomyelitis Vaccine Product and Services
Table 21. Crucell Poliomyelitis Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Crucell Recent Developments/Updates
Table 23. China National Biotech Group Basic Information, Manufacturing Base and Competitors
Table 24. China National Biotech Group Major Business
Table 25. China National Biotech Group Poliomyelitis Vaccine Product and Services
Table 26. China National Biotech Group Poliomyelitis Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. China National Biotech Group Recent Developments/Updates
Table 28. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 29. Eli Lilly Major Business
Table 30. Eli Lilly Poliomyelitis Vaccine Product and Services
Table 31. Eli Lilly Poliomyelitis Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Eli Lilly Recent Developments/Updates
Table 33. Global Poliomyelitis Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 34. Global Poliomyelitis Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Poliomyelitis Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 36. Market Position of Manufacturers in Poliomyelitis Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Poliomyelitis Vaccine Production Site of Key Manufacturer
Table 38. Poliomyelitis Vaccine Market: Company Product Type Footprint
Table 39. Poliomyelitis Vaccine Market: Company Product Application Footprint
Table 40. Poliomyelitis Vaccine New Market Entrants and Barriers to Market Entry
Table 41. Poliomyelitis Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Poliomyelitis Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 43. Global Poliomyelitis Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 44. Global Poliomyelitis Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Poliomyelitis Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Poliomyelitis Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 47. Global Poliomyelitis Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 48. Global Poliomyelitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Global Poliomyelitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Global Poliomyelitis Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Poliomyelitis Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Poliomyelitis Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 53. Global Poliomyelitis Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 54. Global Poliomyelitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 55. Global Poliomyelitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 56. Global Poliomyelitis Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Poliomyelitis Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Poliomyelitis Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 59. Global Poliomyelitis Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 60. North America Poliomyelitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 61. North America Poliomyelitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 62. North America Poliomyelitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 63. North America Poliomyelitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 64. North America Poliomyelitis Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 65. North America Poliomyelitis Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 66. North America Poliomyelitis Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Poliomyelitis Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Poliomyelitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Europe Poliomyelitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Europe Poliomyelitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Europe Poliomyelitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Europe Poliomyelitis Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 73. Europe Poliomyelitis Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 74. Europe Poliomyelitis Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Poliomyelitis Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 77. Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 78. Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 79. Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 80. Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 81. Asia-Pacific Poliomyelitis Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 82. Asia-Pacific Poliomyelitis Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Poliomyelitis Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Poliomyelitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 85. South America Poliomyelitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 86. South America Poliomyelitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 87. South America Poliomyelitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 88. South America Poliomyelitis Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 89. South America Poliomyelitis Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 90. South America Poliomyelitis Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Poliomyelitis Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 93. Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 94. Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 97. Middle East & Africa Poliomyelitis Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 98. Middle East & Africa Poliomyelitis Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Poliomyelitis Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Poliomyelitis Vaccine Raw Material
Table 101. Key Manufacturers of Poliomyelitis Vaccine Raw Materials
Table 102. Poliomyelitis Vaccine Typical Distributors
Table 103. Poliomyelitis Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Poliomyelitis Vaccine Picture
Figure 2. Global Poliomyelitis Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Poliomyelitis Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Poliomyelitis Vaccine ? Examples
Figure 5. Poliomyelitis Vaccine ? Examples
Figure 6. Poliomyelitis Vaccine ? Examples
Figure 7. Oral Poliomyelitis Vaccine Examples
Figure 8. Global Poliomyelitis Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Poliomyelitis Vaccine Consumption Value Market Share by Application in 2023
Figure 10. VAPP Examples
Figure 11. VDPV Examples
Figure 12. Global Poliomyelitis Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Poliomyelitis Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Poliomyelitis Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Poliomyelitis Vaccine Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Poliomyelitis Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Poliomyelitis Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Poliomyelitis Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Poliomyelitis Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Poliomyelitis Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Poliomyelitis Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Poliomyelitis Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Poliomyelitis Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Poliomyelitis Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Poliomyelitis Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Poliomyelitis Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Poliomyelitis Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Poliomyelitis Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Poliomyelitis Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Poliomyelitis Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Poliomyelitis Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Poliomyelitis Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Poliomyelitis Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Poliomyelitis Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Poliomyelitis Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Poliomyelitis Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Poliomyelitis Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Poliomyelitis Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Poliomyelitis Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Poliomyelitis Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Poliomyelitis Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Poliomyelitis Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Poliomyelitis Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Poliomyelitis Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Poliomyelitis Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Poliomyelitis Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Poliomyelitis Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Poliomyelitis Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Poliomyelitis Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Poliomyelitis Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Poliomyelitis Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Poliomyelitis Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Poliomyelitis Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Poliomyelitis Vaccine Market Drivers
Figure 75. Poliomyelitis Vaccine Market Restraints
Figure 76. Poliomyelitis Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Poliomyelitis Vaccine in 2023
Figure 79. Manufacturing Process Analysis of Poliomyelitis Vaccine
Figure 80. Poliomyelitis Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Poliomyelitis Vaccine Picture
Figure 2. Global Poliomyelitis Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Poliomyelitis Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Poliomyelitis Vaccine ? Examples
Figure 5. Poliomyelitis Vaccine ? Examples
Figure 6. Poliomyelitis Vaccine ? Examples
Figure 7. Oral Poliomyelitis Vaccine Examples
Figure 8. Global Poliomyelitis Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Poliomyelitis Vaccine Consumption Value Market Share by Application in 2023
Figure 10. VAPP Examples
Figure 11. VDPV Examples
Figure 12. Global Poliomyelitis Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Poliomyelitis Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Poliomyelitis Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Poliomyelitis Vaccine Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Poliomyelitis Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Poliomyelitis Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Poliomyelitis Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Poliomyelitis Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Poliomyelitis Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Poliomyelitis Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Poliomyelitis Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Poliomyelitis Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Poliomyelitis Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Poliomyelitis Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Poliomyelitis Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Poliomyelitis Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Poliomyelitis Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Poliomyelitis Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Poliomyelitis Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Poliomyelitis Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Poliomyelitis Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Poliomyelitis Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Poliomyelitis Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Poliomyelitis Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Poliomyelitis Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Poliomyelitis Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Poliomyelitis Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Poliomyelitis Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Poliomyelitis Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Poliomyelitis Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Poliomyelitis Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Poliomyelitis Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Poliomyelitis Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Poliomyelitis Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Poliomyelitis Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Poliomyelitis Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Poliomyelitis Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Poliomyelitis Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Poliomyelitis Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Poliomyelitis Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Poliomyelitis Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Poliomyelitis Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Poliomyelitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Poliomyelitis Vaccine Market Drivers
Figure 75. Poliomyelitis Vaccine Market Restraints
Figure 76. Poliomyelitis Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Poliomyelitis Vaccine in 2023
Figure 79. Manufacturing Process Analysis of Poliomyelitis Vaccine
Figure 80. Poliomyelitis Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
